RZL-012

Asset

Injectable small molecule that destroys fat cells to reduce localized fat.

Stage: Stage not known
Modality: Small molecule
Target: Not known; 0
Indications: 0
Trials: 1
Developer

Indications

0

In the full profile

Owner and partners2
Signals2

Every asset’s record: target, stage, trials and the evidence behind it.